A carregar...
Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
INTRODUCTION: Exemestane was approved in 2005 for adjuvant treatment of breast cancer. In this study, we aimed to assess whether it is cost-effective in comparison to available alternatives. MATERIAL AND METHODS: To evaluate the efficacy of exemestane, a systematic review was conducted by searching...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3701982/ https://ncbi.nlm.nih.gov/pubmed/23847669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2013.35347 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|